Related Experiment Video
Updated: Aug 14, 2026

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
Abstract:
The authors studied endocrine ovarian tumor secretions capable of causing a clinic and/or biological syndrome. The plasmatic hormonal determinations and the in-vitro incubation methods revealed that the mesenchymal tumors discharged a full range of steroidsid hormones. Their feminizing or masculinizing clinic aspects depend on each respective hormonal ratio and on the field where they are acting. Ultrastructural studies show that steroid cells derive from the mesenchymal cells and that they often have an ambiguous structure (male or female). Tumors with functional stroma capable of producing steroïds appear to be frequent if correct plasmatic determinations and histochemical studies for their diagnosis are used. The polypeptidic hormonal secretions are much more uncommon. Aside chorioepithelioma and carcinoïde tumors in which the hormonal secretion is in agreement with the histological aspect, ACTH, TSH, PRL, para-hormone or insulin secretions responsible for endocrine paraneoplastic syndromes, may be found as well.
Related Concept Videos
Oogenesis
Cancer
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

